| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 82.135 | 94.679 | 87.898 | 94.070 | 89.711 | 73.242 | 67.652 | 60.350 | 55.820 | 49.007 |
| Total Income - EUR | 100.965 | 114.533 | 99.453 | 104.945 | 100.640 | 83.935 | 493.561 | 70.604 | 47.170 | 49.194 |
| Total Expenses - EUR | 91.358 | 105.237 | 90.930 | 91.088 | 93.884 | 90.199 | 316.044 | 64.902 | 59.775 | 34.096 |
| Gross Profit/Loss - EUR | 9.607 | 9.296 | 8.523 | 13.857 | 6.756 | -6.264 | 177.516 | 5.702 | -12.604 | 15.097 |
| Net Profit/Loss - EUR | 9.607 | 8.349 | 7.458 | 12.916 | 5.859 | -6.938 | 173.450 | 4.991 | -13.131 | 12.420 |
| Employees | 6 | 6 | 4 | 3 | 3 | 2 | 1 | 2 | 2 | 0 |
Check the financial reports for the company - Abemar Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 526.930 | 502.049 | 484.763 | 457.849 | 430.775 | 405.458 | 3.079 | 2.696 | 499 | 11.443 |
| Current Assets | 42.135 | 55.072 | 63.693 | 78.563 | 87.969 | 85.980 | 207.482 | 49.463 | 34.176 | 26.697 |
| Inventories | 14.920 | 16.424 | 16.644 | 19.474 | 18.929 | 19.649 | 18.524 | 16.260 | 9.915 | 9.335 |
| Receivables | 17.369 | 15.347 | 16.416 | 18.310 | 55.876 | 52.972 | 175.966 | 22.580 | 13.140 | 8.124 |
| Cash | 9.845 | 23.301 | 30.633 | 40.780 | 13.164 | 13.359 | 12.992 | 10.624 | 11.121 | 9.238 |
| Shareholders Funds | 166.751 | 173.399 | 177.923 | 187.574 | 189.800 | 179.264 | 198.404 | 42.802 | 19.433 | 31.744 |
| Social Capital | 29.246 | 28.948 | 28.458 | 27.936 | 27.395 | 26.876 | 26.280 | 26.361 | 26.281 | 26.134 |
| Debts | 247.728 | 383.721 | 243.000 | 235.053 | 228.161 | 223.595 | 12.020 | 9.357 | 15.241 | 6.555 |
| Income in Advance | 154.587 | 141.362 | 127.533 | 114.153 | 101.117 | 88.579 | 136 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2042 - 2042" | |||||||||
| CAEN Financial Year |
2042
|
|||||||||
Comments - Abemar Med Srl